[COLL] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[COLL] Collegium Pharmaceutical, Inc.
Announcement Date
06-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -29.65%
YoY- 62.98%
Quarter Report
COLL's Result
COLL's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 127,013 78,843 79,176 72,942 70,176 11,950 408 160.22%
PBT 1,432 9,037 11,566 -6,109 -16,502 -13,263 -26,444 -
Tax 975 991 280 -266 5,868 -334 2 180.40%
NP 457 8,046 11,286 -6,109 -16,502 -13,263 -26,444 -
Tax Rate -68.09% -10.97% -2.42% - - - - -
Total Cost 126,556 70,797 67,890 79,051 86,678 25,213 26,852 29.46%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 0.36 10.21 14.25 -8.38 -23.52 -110.99 -6,481.37 -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS 0.01 0.23 0.33 -0.18 -0.50 -0.45 -1.13 -
EPS Diluted 0.01 0.22 0.32 -0.18 -0.50 -0.45 -1.13 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.